Advertisement Opportunities | About Us | Contact Us | Tell us what you think | Jobs | Shopping | Scandinavian Dating | Archieve


Scandinavian Companies and Market

WeatherForecast



Health and Welbeing





Business Videos








Swedish scientists close to designing a perfect Vaccine for Alzheimer's

Wednesday, 06 June 2012
Swedish scientists are one step closer to designing a breakthrough that could provide cure for severe dementia, Alzheimer's disease. It is shown in a results of a Swedish study published in the medical journal The Lancet Neuology today.

58 patients who have been working with the scientists have all shown signs of mild to moderate form of the disease and 80 percent of them showed good results from the vaccine being administered.

By injecting a little of the substance of beta amyloid, which is found in the brains of Alzheimer's patients, researchers found that the immune system develops antibodies to the substance, which then goes through the bloodstream into the brain and clears away the offending agent.

“Our results show that the new vaccine could be a successful method of treating Alzheimer's in people with mild to moderate Alzheimer's,” said Bengt Winblad, Professor at Karolinska Institute in Huddinge, to Swedish television.

About 120 000 Swedes are suffering from Alzheimer's and there is currently no cure for the most common dementia. The medicines used now can only alleviate symptoms, but now the study shows a very good result with a new vaccine.

The study has been carried out by Bengt Winblad, and several of the nation's leading brain researchers. Unlike a previous attempt to vaccination, ten years ago in the U.S. and Europe, which was discontinued because of severe, side effects and deaths, so has this attempt been successful. The vaccine has been modified and is no longer harmful, according to Professor Bengt Winblad.

Now there should be more and larger studies, both in and outside Sweden, before the vaccine can hopefully be approved and could be in used within the period of about five years. In the long run it may also be necessary to vaccinate people at risk for developing Alzheimer's.
By Scancomark.se Team


Print Friendly and PDF

Please leave a comment about the above article

  • Should be Empty:











Scandinavian Companies and Market



Help | About us | Site map | Advertise with the Us | Terms & Conditions | Privacy Policy | Copyright |

Scandinavian Companies and Market Magazine 2012. | Scandinavian Companies and Market and Scancomark are registered trade mark of Scandinavian Companies and Market.


Back to top